drugset / Trial / NCT05751642
Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1920 in Healthy Participants
RandomizedSequentialTriple-blindBasic science
Summary
This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of single ascending doses (SADs) of ALXN1920 subcutaneous (SC) and of a single dose of ALXN1920 intravenous (IV) in healthy adult participants.
Timeline
- Start
- 2023-04-19
- Primary completion
- 2023-12-04
- Completion
- 2023-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALXN1920 | Unknown | — | Subcutaneous |
Indications
No indication recorded.